Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | peroxisome proliferator-activated receptor gamma | Starlite/ChEMBL | References |
Homo sapiens | peroxisome proliferator-activated receptor delta | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | ecdysteroid receptor | peroxisome proliferator-activated receptor delta | 441 aa | 369 aa | 24.7 % |
Echinococcus granulosus | ecdysone induced protein 78C | peroxisome proliferator-activated receptor gamma | 477 aa | 447 aa | 28.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0021 | 0.5 | 0.5 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.0021 | 0.5 | 0.5 |
Brugia malayi | nuclear hormone receptor | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | coup transcription factor | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | FTZ F1 alpha | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0021 | 0.5 | 0.5 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.0021 | 0.5 | 0.5 |
Brugia malayi | steroid hormone receptor | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0021 | 0.5 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0021 | 0.5 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | FTZ F1 alpha | 0.0021 | 0.5 | 0.5 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0021 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0021 | 0.5 | 0.5 | |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.0021 | 0.5 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.0021 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0021 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0021 | 0.5 | 0.5 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.0021 | 0.5 | 0.5 |
Brugia malayi | nuclear receptor NHR-88 | 0.0021 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | 0 | Displacement of [3H]2-(4-{2-[3-(2,4-difluoro-phenyl)-1-heptyl-ureido]-ethyl}-phenoxy)-2-methyl butyric acid from human PPARalpha | ChEMBL. | 17129725 |
EC50 (functional) | = 25 nM | Agonist activity at human Gal4-PPARdelta expressed in CV1 cells by transactivation assay | ChEMBL. | 17129725 |
EC50 (functional) | = 25 nM | Agonist activity at human Gal4-PPARdelta expressed in CV1 cells by transactivation assay | ChEMBL. | 17129725 |
EC50 (functional) | = 2270 nM | Agonist activity at PPARgamma in CV1 cells by transactivation assay | ChEMBL. | 17129725 |
EC50 (functional) | = 2270 nM | Agonist activity at PPARgamma in CV1 cells by transactivation assay | ChEMBL. | 17129725 |
Efficacy (binding) | < 20 % | Efficacy at human Gal4-PPARalpha expressed in CV1 cells at 10 uM relative to control by transactivation assay | ChEMBL. | 17129725 |
Efficacy (binding) | < 20 % | Efficacy at human Gal4-PPARalpha expressed in CV1 cells at 10 uM relative to control by transactivation assay | ChEMBL. | 17129725 |
IC50 (binding) | = 12 nM | Displacement of [3H]2-(4-{2-[3-(2,4-difluoro-phenyl)-1-heptyl-ureido]-ethyl}-phenoxy)-2-methyl butyric acid from human PPARdelta | ChEMBL. | 17129725 |
IC50 (binding) | = 12 nM | Displacement of [3H]2-(4-{2-[3-(2,4-difluoro-phenyl)-1-heptyl-ureido]-ethyl}-phenoxy)-2-methyl butyric acid from human PPARdelta | ChEMBL. | 17129725 |
IC50 (binding) | = 1530 nM | Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma | ChEMBL. | 17129725 |
IC50 (binding) | = 1530 nM | Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma | ChEMBL. | 17129725 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.